Recently, I went to a private hospital for an emergency – or rather what I deemed as an emergency – and the bill was a staggering $350 for a blood test and a plain-vanilla consultation, triple that of a public hospital for Singapore citizens. As an illustration of the preposterous bill, I incurred a surcharge for a blood test that was done after 5 pm, even though it was 4:50 pm as the laboratory technicians had to work overtime. Case in point, consumers are willing to pay for private healthcare that may seem disproportionate to the value, which in itself is subjective. Private healthcare providers are comparable and that there is an absolute intrinsic value for investors pumping money to back their businesses. Raffles Medical Group (Bloomberg: RMFD SP) caught my attention as it has bee

Sometimes life is stranger than fiction. On paper, Raffles Medical share price should have risen steadily for the past 5 years because of increasing revenue and net profits. For most investors, that would be a reasonable assumption. In reality, Raffles Medical share price plummeted from $1.58 to the current $1.00 level. The massive correction of Raffles Medical share price represented a horrifying 37% decline within the span of three years. The unfolding meltdown of Raffles Medical share price must have scared the living daylight out of investors. Can Raffles Medical share price ever rock again? Perennial Real Estate Holdings versus Raffles Medical My stock analysis of Raffles Medical Group Sure, many analysts claim that the healthcare is an evergreen sector because of Singapore ageing pop

This simple number will help investors better understand three important parts of Raffles Medical Group Ltd's (SGX: BSL) business.

Raffles Medical Group Ltd’s (SGX: BSL) earnings have not grown spectacularly in the past but that could change. Here's why.

Raffles Medical Group Ltd (SGX: BSL) suffers a drop in earnings due to gestational losses from the opening of its new hospital in China.

Let's consider the quality of Raffles Medical Group Ltd's (SGX: BSL) business from the perspective of return on invested capital.

Here's a quick overview of Raffles Medical Group Ltd's (SGX: BSL) historical performance for the last five years.

In the second part of this two part series, we focus on highlighting four more small/mid cap gems that have the potential to become winners in the near future. Investors Takeaway: 4 Small/Mid Cap Winners In The Making Sunpower Group Source: Sunpower Group Sunpower Group (Sunpower) is worth paying attention to. A one-stop solution provider for energy conservation, waste-to-energy and renewable energy projects, Sunpower specializes in the design, R&D, and manufacture of energy conservation products in China. Green Investment Sunpower recorded a strong core net profit growth of 117.5 percent year-on-year, thanks to a strong green investment segment. Its manufacturing revenue also grew by around 40 percent to underpin an improvement in gross margin and operating cash flow. Moving forwa

We're examining Raffles Medical Group Ltd’s (SGX: BSL) management's thoughts on its latest performance and future growth.

DBS Group Holdings Ltd (SGX: D05), Oversea-Chinese Banking Corporation Limited (SGX: O39), and Raffles Medical Group Ltd (SGX: BSL) are three companies to hold for the long-term.

Despite all the good things to like about Raffles Medical Group Ltd (SGX: BSL), here’s one thing not to like about the company now.

I writing a topical email every week to my mailing list. Here’s our last email to subscribers which I thought I share. You can sign up on our mailing list to get the latest updates when it goes out every week.   I’ve just finished a short two-week stint on an executive program at Cambridge for real estate. I head back every couple of months to keep up to date with the latest happenings of the industry and to learn from the expertise of other real estate professionals. Plenty of posts upcoming that will cover some of the key learning points which I think are relevant to investors are on the way. I’ve been talking a lot about bonds and Hyflux over the last few months so I thought I talk about the REIT market. S-REITs in aggregate have delivered robust performance over the

We will look at five reasons why Raffles Medical Group Ltd (SGX: BSL) may qualify as good investment candidate.

We will look at three reasons why Raffles Medical Group Ltd (SGX: BSL) may qualify as good investment candidate.

Raffles Medical Group Ltd (SGX:BSL) and Singapore O&G Ltd (SGX:1D8) are both healthcare stocks. Which is the better buy right now?

By now, you should already have heard of the news that each Singaporean will receive up to $300 from the government from the one-off BiCentennial Bonus. While most attention goes to the one-off BiCentennial Bonus for Singaporeans, there are much more takeaways form this year’s Budget, especially if you are an investor. Here are four key investment takeaways from this year’s Budget to help you position your portfolio for long term investments. Investors Takeaway: 4 Investment Takeaways From SG Budget 2019 More Spending On Healthcare To Tackle Ageing Population Perhaps, the biggest talking point of this Budget (other than the timing of GST hike) is the increase in healthcare spending. A few initiatives were announced in this year’s Budget to help Singaporeans manage healthcare cost

Raffles Medical Group Ltd (SGX:BSL) and Sheng Siong Group Ltd (SGX:OV8) saw their profits grow in 2018.

We will have an overview of the positive and negatives factors from Raffles Group Ltd’s(SGX: BSL) latest result.

The integrated healthcare provider reported a steady set of earnings along with an increase in final dividends.

On 18 February 2019, Finance Minister Heng Swee Keat delivered the Singapore Budget 2019 in Parliament. In the largely expansionary budget for the year, the main highlights were the Bicentennial Bonus, details on the Merdeka Generation Package, expansion in the scope of public spending on healthcare via CHAS, and maintaining a high rate of spending on defence. Read Also: Singapore Budget 2019: Here Are 4 Of The Most Important Announcements That Affect All Of Us In this edition of our 4 Stocks This Week column, we can’t look any further than the stocks that will benefit the most from the Singapore Budget 2019. # 1 ST Engineering (SGX: S63) During the Singapore Budget 2019, one of the first things Minister Heng spoke about was the need for our country to stay vigilant to the threats around